Consumer healthcare giant Kenvue has completed the global media and creative agency reviews it began three months ago, the company confirmed today.   

A company spokesperson confirmed that Publicis will lead media, commerce, healthcare professional, and technology support as well as creative and production for the Neutrogena brand.  

The company spends an estimated $1.35 billion on measured media annually, according to agency research firm COMvergence. 

WPP will lead creative and production for all brands except Neutrogena.  

“This powerful combination gives Kenvue the strongest blend of enduring creativity and modern precision to elevate brand building,” the spokesperson said. “We are very grateful for the tremendous partnership of MediaSense who supported the review and deeply appreciative of all the exceptionally talented teams who participated in the pitch.” 

Interpublic, now part of Omnicom, was the primary media incumbent, while Publicis Media had previously handled the Asia-Pacific region.  

Creative incumbents included FCB and Deutsch and Omnicom’s BBDO. FCB, the IPG creative network, was retired as a go-to-market brand with the acquisition by Omnicom, and the agency has been folded into BBDO.  

Kenvue is the former consumer healthcare division of Johnson & Johnson, which spun the unit off in 2022. Its brands include Tylenol, Band-aid, Listerine, Neutrogena, Aveeno and more.